New York Times CENTER-LEFT (-1.0) Reliability: 8.0/10

The Gamble Behind a Takeover of Kenvue, Maker of Tylenol

✍️ Andrew Ross Sorkin, Bernhard Warner, Sarah Kessler, Michael J. De La Merced, Niko Gallogly, Ian Mount, Lauren Hirsch 📅 November 04, 2025 12:00 AM 🕐 Scraped: November 04, 2025

Summary: Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.

A risky wager

Kimberly-Clark’s $40 billion deal for Kenvue, the embattled maker of Tylenol and other consumer products, seemingly flies in the face of two M.&A

📰

Continue Reading on New York Times

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Andrew Ross Sorkin, Bernhard Warner, Sarah Kessler, Michael J. De La Merced, Niko Gallogly, Ian Mount, Lauren Hirsch

Original Publisher

🌍 New York Times

CENTER-LEFT Bias (-1.0)

Published Date

November 04, 2025 at 12:00 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only